Epigenetic IVD Tests for Personalized Precision Medicine in Cancer

Epigenetic IVD Tests for Personalized Precision Medicine in Cancer

Epigenetic alterations play a key role in the initiation and progression of cancer. Therefore, it is possible to use epigenetic marks as biomarkers for predictive and precision medicine in cancer. Precision medicine is poised to impact clinical practice, patients, and healthcare systems. The objecti...

Full description

Bibliographic Details
Main Authors:	Jesús Beltrán-García, Rebeca Osca-Verdegal, Salvador Mena-Mollá, José Luis García-Giménez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-06-01
Series:	Frontiers in Genetics
Subjects:	precision medicine epigenetic biomarker In Vitro Diagnostic (IVD) DNA methylation miRNA cfDNA
Online Access:	https://www.frontiersin.org/article/10.3389/fgene.2019.00621/full

Similar Items

DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study
by: Sheila Lorente-Pozo, et al.
Published: (2021-02-01)

Circular RNAs in Sepsis: Biogenesis, Function, and Clinical Significance
by: Jesús Beltrán-García, et al.
Published: (2020-06-01)

Epigenetic Regulation in the Pathogenesis of Sjögren Syndrome and Rheumatoid Arthritis
by: José Santiago Ibáñez-Cabellos, et al.
Published: (2019-11-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma
by: Zac Chatterton, et al.
Published: (2021-07-01)

Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females
by: Yu-Feng Huang, et al.
Published: (2018-02-01)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
by: Dilys Lam, et al.
Published: (2020-10-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

A new primer construction technique that effectively increases amplification of rare mutant templates in samples
by: Jr-Kai Huang, et al.
Published: (2019-08-01)

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
by: Patricia Mondelo-Macía, et al.
Published: (2021-01-01)

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR
by: Tara K. Sigdel, et al.
Published: (2018-12-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
by: Stefan Grabuschnig, et al.
Published: (2020-10-01)

Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs
by: Jason Chibuk, et al.
Published: (2021-03-01)

Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions
by: Kuo-Ping Chiu, et al.
Published: (2019-08-01)

Comparing cell‐free circulating tumor DNA mutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
by: Alok R. Khandelwal, et al.
Published: (2020-10-01)

DNA-Loaded Extracellular Vesicles in Liquid Biopsy: Tiny Players With Big Potential?
by: Susana García-Silva, et al.
Published: (2021-01-01)

Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine
by: Claudio Luchini, et al.
Published: (2019-08-01)

The Development of a Personalised Training Framework: Implementation of Emerging Technologies for Performance
by: Craig Pickering, et al.
Published: (2019-05-01)

Fetal sex discordance
by: Álvaro López Soto, et al.
Published: (2020-09-01)

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules
by: Quan‐Xing Liu, et al.
Published: (2021-07-01)

Maintenance of Glutathione Levels: importance in epigenetic regulation
by: Federico V Pallardó, et al.
Published: (2014-05-01)

<i>ANK2</i> Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
by: Johannes J. Schabort, et al.
Published: (2020-11-01)

Neutrophil extracellular traps in stored canine red blood cell units
by: Erin R. McQuinn, et al.
Published: (2020-09-01)

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
by: Vinh Thanh Tran, et al.
Published: (2020-08-01)

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
by: Sohan Punia, et al.
Published: (2021-04-01)

Implementing Precision Medicine in Human Frailty through Epigenetic Biomarkers
by: José Luis García-Giménez, et al.
Published: (2021-02-01)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
by: Daniel Fernandez-Garcia, et al.
Published: (2019-12-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report
by: Nuria Balaguer, et al.
Published: (2021-01-01)

Concentrations of Plasma Nucleosomes but Not Cell-Free DNA Are Prognostic in Dogs Following Trauma
by: Jo-Annie Letendre, et al.
Published: (2018-07-01)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
by: Sadakatsu Ikeda, et al.
Published: (2018-06-01)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
by: Maxim Ivanov, et al.
Published: (2019-03-01)

Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
by: Wilson V. Chan, et al.
Published: (2018-01-01)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
by: Yuyuan Zhang, et al.
Published: (2021-09-01)

An automated high throughput solution for DNA extraction and bisulfite-conversion from high volume liquid biopsy specimens: sample preparation for epigenetic analysis
by: Sebastian Rausch, et al.
Published: (2019-08-01)